{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:40:26Z","timestamp":1785512426130,"version":"3.56.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea","award":["1020350"],"award-info":[{"award-number":["1020350"]}]},{"name":"National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea","award":["1420190"],"award-info":[{"award-number":["1420190"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10549-015-3495-z","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T07:22:13Z","timestamp":1437376933000},"page":"659-665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2"],"prefix":"10.1007","volume":"152","author":[{"given":"Boyoung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Dowty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choonghyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aung K.","family":"Win","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunyoung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue K.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"issue":"2","key":"3495_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","volume":"108","author":"AR Venkitaraman","year":"2002","unstructured":"Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108(2):171\u2013182","journal-title":"Cell"},{"issue":"6559","key":"3495_CR2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789\u2013792. doi: 10.1038\/378789a0","journal-title":"Nature"},{"issue":"8","key":"3495_CR3","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1200\/JCO.2005.10.035","volume":"23","author":"SA Narod","year":"2005","unstructured":"Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23(8):1656\u20131663. doi: 10.1200\/jco.2005.10.035","journal-title":"J Clin Oncol"},{"issue":"1","key":"3495_CR4","first-page":"265","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium. Am J Hum Genet 56(1):265\u2013271","journal-title":"Am J Hum Genet"},{"issue":"3","key":"3495_CR5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62(3):676\u2013689","journal-title":"Am J Hum Genet"},{"issue":"9","key":"3495_CR6","first-page":"741","volume":"8","author":"JL Hopper","year":"1999","unstructured":"Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ (1999) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology 8(9):741\u2013747","journal-title":"Oncology"},{"issue":"1","key":"3495_CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bjc.6603535","volume":"96","author":"E Levy-Lahad","year":"2007","unstructured":"Levy-Lahad E, Friedman E (2007) Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer 96(1):11\u201315. doi: 10.1038\/sj.bjc.6603535","journal-title":"Br J Cancer"},{"issue":"20","key":"3495_CR8","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401\u20131408. doi: 10.1056\/nejm199705153362001","journal-title":"N Engl J Med"},{"issue":"14","key":"3495_CR9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","volume":"91","author":"E Warner","year":"1999","unstructured":"Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91(14):1241\u20131247","journal-title":"J Natl Cancer Inst"},{"issue":"9137","key":"3495_CR10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(98)03300-5","volume":"352","author":"S Thorlacius","year":"1998","unstructured":"Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjord JE (1998) Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352(9137):1337\u20131339","journal-title":"Lancet"},{"issue":"10","key":"3495_CR11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","volume":"83","author":"Anglian Breast Cancer Study Group","year":"2000","unstructured":"Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83(10):1301\u20131308. doi: 10.1054\/bjoc.2000.1407","journal-title":"Br J Cancer"},{"issue":"5","key":"3495_CR12","first-page":"467","volume":"10","author":"JM Satagopan","year":"2001","unstructured":"Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB (2001) The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomark Prev 10(5):467\u2013473","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"3495_CR13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","volume":"68","author":"D Thompson","year":"2001","unstructured":"Thompson D, Easton D (2001) Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68(2):410\u2013419. doi: 10.1086\/318181","journal-title":"Am J Hum Genet"},{"issue":"18","key":"3495_CR14","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton DF (2002) Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94(18):1358\u20131365","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"3495_CR15","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1158\/1055-9965.EPI-12-0229","volume":"21","author":"YC Ding","year":"2012","unstructured":"Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, Nathanson KL, Rebbeck TR, Jakubowska A, Lubinski J, Jaworska K, Durda K, Gronwald J, Huzarski T, Cybulski C, Byrski T, Osorio A, Cajal TR, Stavropoulou AV, Benitez J, Hamann U, Rookus M, Aalfs CM, de Lange JL, Meijers-Heijboer HE, Oosterwijk JC, van Asperen CJ, Gomez Garcia EB, Hoogerbrugge N, Jager A, van der Luijt RB, Easton DF, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Izatt L, Eeles R, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Godwin AK, Pathak H, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S, Barjhoux L, Leone M, Gauthier-Villars M, Caux-Moncoutier V, de Pauw A, Hardouin A, Berthet P, Dreyfus H, Ferrer SF, Collonge-Rame MA, Sokolowska J, Buys S, Daly M, Miron A, Terry MB, Chung W, John EM, Southey M, Goldgar D, Singer CF, Tea MK, Gschwantler-Kaulich D, Fink-Retter A, Hansen TV, Ejlertsen B, Johannsson OT, Offit K, Sarrel K, Gaudet MM, Vijai J, Robson M, Piedmonte MR, Andrews L, Cohn D, DeMars LR, DiSilvestro P, Rodriguez G, Toland AE, Montagna M, Agata S, Imyanitov E, Isaacs C, Janavicius R, Lazaro C, Blanco I, Ramus SJ, Sucheston L, Karlan BY, Gross J, Ganz PA, Beattie MS, Schmutzler RK, Wappenschmidt B, Meindl A, Arnold N, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Nevanlinna H, Aittomaki K, Simard J, Spurdle AB, Beesley J, Chen X, Tomlinson GE, Weitzel J, Garber JE, Olopade OI, Rubinstein WS, Tung N, Blum JL, Narod SA, Brummel S, Gillen DL, Lindor N, Fredericksen Z, Pankratz VS, Couch FJ, Radice P, Peterlongo P, Greene MH, Loud JT, Mai PL, Andrulis IL, Glendon G, Ozcelik H, Gerdes AM, Thomassen M, Jensen UB, Skytte AB, Caligo MA, Lee A, Chenevix-Trench G, Antoniou AC, Neuhausen SL (2012) A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomark Prev 21(8):1362\u20131370. doi: 10.1158\/1055-9965.epi-12-0229","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3495_CR16","doi-asserted-by":"crossref","unstructured":"Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Healey S, Sinilnikova OM, Caligo MA, Loman N, Harbst K, Lindblom A, Arver B, Rosenquist R, Karlsson P, Nathanson K, Domchek S, Rebbeck T, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowowcka-Perlowska E, Osorio A, Duran M, Andres R, Benitez J, Hamann U, Hogervorst FB, van Os TA, Verhoef S, Meijers-Heijboer HE, Wijnen J, Gomez Garcia EB, Ligtenberg MJ, Kriege M, Collee JM, Ausems MG, Oosterwijk JC, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Jacobs C, Eeles R, Adlard J, Davidson R, Cole T, Cook J, Paterson J, Douglas F, Brewer C, Hodgson S, Morrison PJ, Walker L, Rogers MT, Donaldson A, Dorkins H, Godwin AK, Bove B, Stoppa-Lyonnet D, Houdayer C, Buecher B, de Pauw A, Mazoyer S, Calender A, Leone M, Bressac-de Paillerets B, Caron O, Sobol H, Frenay M, Prieur F, Ferrer SU, Mortemousque I, Buys S, Daly M, Miron A, Terry MU, Hopper JL, John EM, Southey M, Goldgar D, Singer CF, Fink-Retter A, Tea MK, Kaulich DU, Hansen TV, Nielsen FC, Barkardottir RB, Gaudet M, Kirchhoff T, Joseph V, Dutra-Clarke A, Offit K, Piedmonte M, Kirk J, Cohn D, Hurteau J, Byron J, Fiorica J, Toland AE, Montagna M, Oliani C, Imyanitov E, Isaacs C, Tihomirova L, Blanco I, Lazaro C, Teule A, Valle JD, Gayther SA, Odunsi K, Gross J, Karlan BY, Olah E, Teo SH, Ganz PA, Beattie MS, Dorfling CM, van Rensburg EU, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Schafer D, Caldes T, de la Hoya M, Nevanlinna H, Muranen TA, Lesperance B, Spurdle AB, Neuhausen SL, Ding YC, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Bonanni B, Bernard L, Dolcetti R, Papi L, Ottini L, Radice P, Greene MH, Loud JT, Andrulis IL, Ozcelik H, Mulligan AU, Glendon G, Thomassen M, Gerdes AM, Jensen UB, Skytte AB, Kruse TA, Chenevix-Trench G, Couch FJ, Simard J, Easton DF (2012) Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and\/or BRCA2 mutation carriers. Breast Cancer Res BCR 14(1):R33. doi: 10.1186\/bcr3121","DOI":"10.1186\/bcr3121"},{"issue":"3","key":"3495_CR17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10549-010-1068-8","volume":"125","author":"I Catucci","year":"2011","unstructured":"Catucci I, Verderio P, Pizzamiglio S, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Ripamonti CB, Pasini B, Barile M, Viel A, Giannini G, Papi L, Varesco L, Martayan A, Riboni M, Volorio S, Radice P, Peterlongo P (2011) The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. Breast Cancer Res Treat 125(3):855\u2013860. doi: 10.1007\/s10549-010-1068-8","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3495_CR18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130. doi: 10.1086\/375033","journal-title":"Am J Hum Genet"},{"issue":"5645","key":"3495_CR19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646. doi: 10.1126\/science.1088759","journal-title":"Science"},{"issue":"12","key":"3495_CR20","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejca.2010.04.018","volume":"46","author":"S Iodice","year":"2010","unstructured":"Iodice S, Barile M, Rotmensz N, Feroce I, Bonanni B, Radice P, Bernard L, Maisonneuve P, Gandini S (2010) Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: a meta-analysis. Eur J Cancer 46(12):2275\u20132284. doi: 10.1016\/j.ejca.2010.04.018","journal-title":"Eur J Cancer"},{"issue":"1","key":"3495_CR21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10549-009-0394-1","volume":"119","author":"RL Milne","year":"2010","unstructured":"Milne RL, Osorio A, Ramon y Cajal T, Baiget M, Lasa A, Diaz-Rubio E, de la Hoya M, Caldes T, Teule A, Lazaro C, Blanco I, Balmana J, Sanchez-Olle G, Vega A, Blanco A, Chirivella I, Esteban Cardenosa E, Duran M, Velasco E, Martinez de Duenas E, Tejada MI, Miramar MD, Calvo MT, Guillen-Ponce C, Salazar R, San Roman C, Urioste M, Benitez J (2010) Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 119(1):221\u2013232. doi: 10.1007\/s10549-009-0394-1","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"3495_CR22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.clon.2010.11.007","volume":"23","author":"SA Han","year":"2011","unstructured":"Han SA, Park SK, Ahn SH, Lee MH, Noh DY, Kim LS, Noh WC, Jung Y, Kim KS, Kim SW (2011) The Korean Hereditary Breast Cancer (KOHBRA) study: protocols and interim report. Clin Oncol 23(7):434\u2013441. doi: 10.1016\/j.clon.2010.11.007","journal-title":"Clin Oncol"},{"issue":"6","key":"3495_CR23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/gepi.1370050611","volume":"5","author":"K Lange","year":"1988","unstructured":"Lange K, Weeks D, Boehnke M (1988) Programs for pedigree analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 5(6):471\u2013472. doi: 10.1002\/gepi.1370050611","journal-title":"Genet Epidemiol"},{"issue":"2","key":"3495_CR24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jmedgenet-2013-101974","volume":"51","author":"RM Brohet","year":"2014","unstructured":"Brohet RM, Velthuizen ME, Hogervorst FB, Meijers-Heijboer HE, Seynaeve C, Collee MJ, Verhoef S, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia E, Menko F, Oosterwijk JC, Devilee P, van\u2019t Veer LJ, van Leeuwen FE, Easton DF, Rookus MA, Antoniou AC (2014) Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet 51(2):98\u2013107. doi: 10.1136\/jmedgenet-2013-101974","journal-title":"J Med Genet"},{"issue":"9","key":"3495_CR25","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1078-0432.CCR-07-4436","volume":"14","author":"RL Milne","year":"2008","unstructured":"Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Diez O, Alonso MC, Lazaro C, Blanco I, Sanchez-de-Abajo A, Caldes T, Blanco A, Grana B, Duran M, Velasco E, Chirivella I, Cardenosa EE, Tejada MI, Beristain E, Miramar MD, Calvo MT, Martinez E, Guillen C, Salazar R, San Roman C, Antoniou AC, Urioste M, Benitez J (2008) The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res 14(9):2861\u20132869. doi: 10.1158\/1078-0432.ccr-07-4436","journal-title":"Clin Cancer Res"},{"key":"3495_CR26","unstructured":"The Korea Central Cancer Registry, National Cancer Center (2012) Annual report of cancer statistics in Korea in 2010, Ministry of Health and Welfare"},{"issue":"10","key":"3495_CR27","doi-asserted-by":"crossref","first-page":"e76736","DOI":"10.1371\/journal.pone.0076736","volume":"8","author":"B Park","year":"2013","unstructured":"Park B, Ma SH, Shin A, Chang MC, Choi JY, Kim S, Han W, Noh DY, Ahn SH, Kang D, Yoo KY, Park SK (2013) Korean risk assessment model for breast cancer risk prediction. PLoS One 8(10):e76736. doi: 10.1371\/journal.pone.0076736","journal-title":"PLoS One"},{"issue":"3","key":"3495_CR28","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10549-012-2022-8","volume":"134","author":"E Kang","year":"2012","unstructured":"Kang E, Park SK, Yang JJ, Park B, Lee MH, Lee JW, Suh YJ, Lee JE, Kim HA, Oh SJ, Kim SW (2012) Accuracy of BRCA1\/2 mutation prediction models in Korean breast cancer patients. Breast Cancer Res Treat 134(3):1189\u20131197. doi: 10.1007\/s10549-012-2022-8","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"3495_CR29","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329\u20131333. doi: 10.1200\/jco.2006.09.1066","journal-title":"J Clin Oncol"},{"issue":"4","key":"3495_CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00008469-199407000-00004","volume":"3","author":"B Theis","year":"1994","unstructured":"Theis B, Boyd N, Lockwood G, Tritchler D (1994) Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 3(4):321\u2013327","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"3495_CR31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0749-3797(02)00593-7","volume":"24","author":"A Ziogas","year":"2003","unstructured":"Ziogas A, Anton-Culver H (2003) Validation of family history data in cancer family registries. Am J Prev Med 24(2):190\u2013198","journal-title":"Am J Prev Med"},{"issue":"3","key":"3495_CR32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0040-5809(86)90042-0","volume":"30","author":"WJ Ewens","year":"1986","unstructured":"Ewens WJ, Shute NC (1986) A resolution of the ascertainment sampling problem. I. Theory. Theor Popul Biol 30(3):388\u2013412","journal-title":"Theor Popul Biol"},{"issue":"5","key":"3495_CR33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/jmg.39.5.335","volume":"39","author":"J Carayol","year":"2002","unstructured":"Carayol J, Khlat M, Maccario J, Bonaiti-Pellie C (2002) Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely over estimated. J Med Genet 39(5):335\u2013339","journal-title":"J Med Genet"},{"issue":"2","key":"3495_CR34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/gepi.20007","volume":"27","author":"J Carayol","year":"2004","unstructured":"Carayol J, Bonaiti-Pellie C (2004) Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset. Genet Epidemiol 27(2):109\u2013117. doi: 10.1002\/gepi.20007","journal-title":"Genet Epidemiol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3495-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3495-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:43:15Z","timestamp":1559234595000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3495-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3495"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3495-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,21]]}}}